Although the introduction of new specialty drugs and increased investments into personal health data security, moderating forces will keep healthcare spending growth in check in 2016, according to a report from PwC's Health Research Institute.
Although the introduction of new specialty drugs and increased investments into personal health data security, moderating forces will keep healthcare spending growth in check in 2016, according to a report from PwC’s Health Research Institute (HRI).
The annual Medical Cost Trend: Behind the Numbers report projects medical inflation will be 6.5% in 2016, slightly lower than the 6.8% projected for 2015. This continued slowdown in healthcare spending growth represents a 10-year trend of slowing employer medical cost-trend growth, according to PwC. However, it is still notable that medical inflation continues to outpace general economic inflation.
In 2016, there are 3 key factors expected to reduce medical spending growth: the Affordable Care Act’s “Cadillac tax”; greater adoption of virtual care technology; and new health advisers steering consumers to more efficient healthcare.
Furthermore, after taking into account likely changes in benefit design, such as narrow networks and higher deductibles and co-pays, the net growth rate should drop to 4.5% in 2015.
“While the health industry has improved in efficiency over the past decade, the slowing employer medical cost growth is due to the increased role of savvy health consumers facing higher cost-sharing responsibilities and more complex decisions,” Kelly Barnes, PwC’s US health industries leader, said in a statement.
However, high cost-sharing can also be a barrier to care. A PwC HRI consumer survey found that due to cost shifting, in the last 12 months 28% of consumers skipped seeing a doctor and 24% skipped prescription medicine or too less than prescribed.
High-deductible plans have continued to grow in popularity with 31% of employers offering them, up from 26% last year. However, employers are also offering more health plans with 4.1 options today compared with 2.9 options on average last year.
“The New Health Economy is reshaping the landscape for the employer-based health insurance plans that continue to cover most Americans,” Michael Thompson, principal of PwC’s human resource services practice, said. “One result is that consumers have more plan choices than ever before. But at the same time, the pressure on employers to control their health budgets means that employees are having to pick up more of their healthcare tab than ever before.”
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More